Regent Peak Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$334K Sell
769
-20
-3% -$8.03K 0.08% 111
2024
Q4
$291K Sell
789
-75
-9% -$31.4K 0.07% 127
2024
Q3
$449K Buy
864
+2
+0.2% +$1.07K 0.1% 93
2024
Q2
$467K Buy
862
+26
+3% +$13.7K 0.11% 91
2024
Q1
$433K Buy
836
+14
+2% +$6.96K 0.11% 93
2023
Q4
$388K Buy
822
+29
+4% +$13.4K 0.11% 96
2023
Q3
$345K Buy
793
+5
+0.6% +$2.27K 0.11% 99
2023
Q2
$350K Sell
788
-164
-17% -$75.7K 0.1% 96
2023
Q1
$438K Buy
952
+15
+2% +$7.14K 0.14% 82
2022
Q4
$481K Buy
937
+19
+2% +$9.65K 0.16% 85
2022
Q3
$416K Buy
918
+3
+0.3% +$1.44K 0.15% 91
2022
Q2
$441K Buy
915
+28
+3% +$13.9K 0.14% 93
2022
Q1
$436K Buy
887
+11
+1% +$5.03K 0.13% 98
2021
Q4
$406K Sell
876
-7
-0.8% -$2.94K 0.11% 104
2021
Q3
$329K Buy
883
+14
+2% +$5.32K 0.09% 119
2021
Q2
$334K Sell
869
-40
-4% -$15.3K 0.09% 118
2021
Q1
$326K Buy
909
+27
+3% +$8.68K 0.11% 110
2020
Q4
$283K Buy
+882
New +$271K 0.09% 113

Other funds holding ELV

Regent Peak Wealth Advisors's ELV Position: Q1 2025 in Review

Regent Peak Wealth Advisors reduced its Elevance Health (ELV) stake by 2.5% in Q1 2025, selling an estimated $8.03K and leaving 769 shares worth $334K. The position accounts for 0.08% of the portfolio, ranked #111.

Regent Peak Wealth Advisors first reported a position in ELV in Q4 2020 and has held it in 18 quarters since. The position peaked at $481K in Q4 2022. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Regent Peak Wealth Advisors held 769 shares of Elevance Health worth $334K as of Q1 2025.
  • Regent Peak Wealth Advisors sold 20 Elevance Health shares in Q1 2025, an estimated $8.03K.
  • Elevance Health made up 0.08% of Regent Peak Wealth Advisors's portfolio in Q1 2025, its #111 holding.
  • Regent Peak Wealth Advisors first reported a position in Elevance Health in Q4 2020 and has held it in 18 quarters since.
  • Regent Peak Wealth Advisors's Elevance Health position peaked at $481K in Q4 2022.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Regent Peak Wealth Advisors's 13F filing for Q1 2025, filed 14 Apr 2025.